Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2016 1
2018 1
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men.
Popping S, Hullegie SJ, Boerekamps A, Rijnders BJA, de Knegt RJ, Rockstroh JK, Verbon A, Boucher CAB, Nichols BE, van de Vijver DAMC. Popping S, et al. PLoS One. 2019 Jan 10;14(1):e0210179. doi: 10.1371/journal.pone.0210179. eCollection 2019. PLoS One. 2019. PMID: 30629662 Free PMC article.
BACKGROUND: Treatment of hepatitis C virus infections (HCV) with direct acting antivirals (DAA) can prevent new infections since cured individuals cannot transmit HCV. ...We assessed the epidemiological impact and cost-effectiveness of treatment initiation in …
BACKGROUND: Treatment of hepatitis C virus infections (HCV) with direct acting antivirals (DAA) can prevent new infections sin …
Modelling the impact of deferring HCV treatment on liver-related complications in HIV coinfected men who have sex with men.
Zahnd C, Salazar-Vizcaya L, Dufour JF, Müllhaupt B, Wandeler G, Kouyos R, Estill J, Bertisch B, Rauch A, Keiser O; Swiss HIV; Swiss Hepatitis C Cohort Studies. Zahnd C, et al. J Hepatol. 2016 Jul;65(1):26-32. doi: 10.1016/j.jhep.2016.02.030. Epub 2016 Feb 26. J Hepatol. 2016. PMID: 26921687 Free article.
Our goal was to estimate the long term impact of deferring HCV treatment for men who have sex with men (MSM) who are coinfected with HIV and often have multiple risk factors for liver disease progression. METHODS: We developed an individual-base …
Our goal was to estimate the long term impact of deferring HCV treatment for men who have sex with men (MSM) who are co …
Modelling the impact of HIV disease on mortality in gay and bisexual men.
Hogg RS, Strathdee SA, Craib KJ, O'Shaughnessy MV, Montaner JS, Schechter MT. Hogg RS, et al. Int J Epidemiol. 1997 Jun;26(3):657-61. doi: 10.1093/ije/26.3.657. Int J Epidemiol. 1997. PMID: 9222793
OBJECTIVE: To assess how HIV infection and AIDS (HIV/AIDS) impacts on mortality rates for gay and bisexual men. METHODS: Vital statistics data were obtained for a large Canadian urban centre from 1987 to 1992. ...Age-specific mo
OBJECTIVE: To assess how HIV infection and AIDS (HIV/AIDS) impacts on mortality rates for gay and bise
HIV and syphilis testing preferences among men who have sex with men and among transgender women in Lima, Peru.
Bristow CC, Kojima N, Lee SJ, Leon SR, Ramos LB, Konda KA, Brown B, Caceres CF, Klausner JD. Bristow CC, et al. PLoS One. 2018 Oct 29;13(10):e0206204. doi: 10.1371/journal.pone.0206204. eCollection 2018. PLoS One. 2018. PMID: 30372465 Free PMC article.
BACKGROUND: Men who have sex with men (MSM) and transgender women in Peru are at high risk for acquiring syphilis and HIV infection. The World Health Organization highly recommends screening for HIV and syphilis to reduce morbidity and mortality
BACKGROUND: Men who have sex with men (MSM) and transgender women in Peru are at high risk for acquiring syphilis and HIV
Monitoring progress towards the first UNAIDS 90-90-90 target in key populations living with HIV in Norway.
Whittaker R, Case KK, Nilsen Ø, Blystad H, Cowan S, Kløvstad H, van Sighem A. Whittaker R, et al. BMC Infect Dis. 2020 Jun 26;20(1):451. doi: 10.1186/s12879-020-05178-1. BMC Infect Dis. 2020. PMID: 32590964 Free PMC article.
METHODS: We used the European Centre for Disease Prevention and Control (ECDC) HIV Modelling Tool on Norwegian HIV surveillance data through 2018 to estimate incidence, time from infection to diagnosis, PLHIV, and the number and proportion undiagnosed. …
METHODS: We used the European Centre for Disease Prevention and Control (ECDC) HIV Modelling Tool on Norwegian HIV
Feedback